TD Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $271M | Sell |
350,923
-46,629
| -12% | -$35.7M | 0.22% | 87 |
|
|
2025
Q4 | $307M | Buy |
397,552
+23,288
| +6% | +$15.8M | 0.25% | 76 |
|
|
2025
Q3 | $210M | Buy |
374,264
+51,407
| +16% | +$29.1M | 0.17% | 113 |
|
|
2025
Q2 | $169M | Sell |
322,857
-29,030
| -8% | -$16.2M | 0.14% | 143 |
|
|
2025
Q1 | $223M | Sell |
351,887
-7,502
| -2% | -$5.16M | 0.21% | 100 |
|
|
2024
Q4 | $256M | Buy |
359,389
+29,322
| +9% | +$24.6M | 0.23% | 90 |
|
|
2024
Q3 | $344M | Sell |
330,067
-21,478
| -6% | -$23.9M | 0.3% | 68 |
|
|
2024
Q2 | $369M | Buy |
351,545
+82,034
| +30% | +$79.5M | 0.34% | 59 |
|
|
2024
Q1 | $259M | Buy |
269,511
+166,998
| +163% | +$159M | 0.24% | 95 |
|
|
2023
Q4 | $90M | Sell |
102,513
-77,754
| -43% | -$64M | 0.09% | 199 |
|
|
2023
Q3 | $148M | Buy |
180,267
+70,628
| +64% | +$55.5M | 0.18% | 105 |
|
|
2023
Q2 | $78.8M | Sell |
109,639
-2,495
| -2% | -$1.92M | 0.09% | 174 |
|
|
2023
Q1 | $92.1M | Buy |
112,134
+9,469
| +9% | +$7.14M | 0.11% | 158 |
|
|
2022
Q4 | $74.1M | Buy |
102,665
+10,323
| +11% | +$7.62M | 0.09% | 179 |
|
|
2022
Q3 | $63.9M | Buy |
92,342
+5,048
| +6% | +$3.18M | 0.08% | 194 |
|
|
2022
Q2 | $51.6M | Buy |
87,294
+5,855
| +7% | +$3.81M | 0.06% | 252 |
|
|
2022
Q1 | $56.9M | Sell |
81,439
-203
| -0.2% | -$128K | 0.05% | 268 |
|
|
2021
Q4 | $51.6M | Buy |
81,642
+1,634
| +2% | +$1M | 0.04% | 324 |
|
|
2021
Q3 | $48.4M | Sell |
80,008
-780
| -1% | -$484K | 0.05% | 291 |
|
|
2021
Q2 | $46.4M | Buy |
80,788
+2,104
| +3% | +$1.07M | 0.05% | 306 |
|
|
2021
Q1 | $37.2M | Buy |
78,684
+2,826
| +4% | +$1.38M | 0.04% | 333 |
|
|
2020
Q4 | $36.6M | Buy |
75,858
+1,146
| +2% | +$619K | 0.04% | 315 |
|
|
2020
Q3 | $41.8M | Buy |
74,712
+5,258
| +8% | +$3.19M | 0.06% | 249 |
|
|
2020
Q2 | $43.3M | Buy |
69,454
+8,290
| +14% | +$4.71M | 0.06% | 224 |
|
|
2020
Q1 | $29.9M | Buy |
61,164
+8,665
| +17% | +$3.57M | 0.05% | 257 |
|
|
2019
Q4 | $19.7M | Sell |
52,499
-5,867
| -10% | -$1.97M | 0.03% | 392 |
|
|
2019
Q3 | $16.2M | Buy |
58,366
+1,655
| +3% | +$490K | 0.02% | 405 |
|
|
2019
Q2 | $17.8M | Sell |
56,711
-10,910
| -16% | -$3.63M | 0.03% | 398 |
|
|
2019
Q1 | $27.8M | Buy |
67,621
+19,567
| +41% | +$8.06M | 0.04% | 310 |
|
|
2018
Q4 | $17.9M | Buy |
48,054
+2,299
| +5% | +$841K | 0.03% | 369 |
|
|
2018
Q3 | $18.5M | Sell |
45,755
-3,988
| -8% | -$1.52M | 0.03% | 403 |
|
|
2018
Q2 | $17.2M | Buy |
49,743
+1,634
| +3% | +$511K | 0.03% | 406 |
|
|
2018
Q1 | $16.6M | Sell |
48,109
-385
| -0.8% | -$134K | 0.03% | 421 |
|
|
2017
Q4 | $18.2M | Sell |
48,494
-153
| -0.3% | -$62K | 0.03% | 404 |
|
|
2017
Q3 | $21.8M | Sell |
48,647
-3,577
| -7% | -$1.7M | 0.03% | 371 |
|
|
2017
Q2 | $25.6M | Sell |
52,224
-11,989
| -19% | -$5.25M | 0.04% | 337 |
|
|
2017
Q1 | $24.9M | Sell |
64,213
-405
| -0.6% | -$150K | 0.04% | 348 |
|
|
2016
Q4 | $23.7M | Sell |
64,618
-3,226
| -5% | -$1.23M | 0.04% | 329 |
|
|
2016
Q3 | $27.3M | Sell |
67,844
-18,479
| -21% | -$7.41M | 0.05% | 296 |
|
|
2016
Q2 | $30.1M | Sell |
86,323
-11,011
| -11% | -$4.24M | 0.05% | 266 |
|
|
2016
Q1 | $35.1M | Sell |
97,334
-16,631
| -15% | -$6.85M | 0.07% | 237 |
|
|
2015
Q4 | $61.9M | Buy |
113,965
+3,348
| +3% | +$1.81M | 0.12% | 148 |
|
|
2015
Q3 | $51.5M | Buy |
110,617
+11,800
| +12% | +$6.34M | 0.1% | 169 |
|
|
2015
Q2 | $50.4M | Buy |
98,817
+12,227
| +14% | +$5.97M | 0.09% | 178 |
|
|
2015
Q1 | $39.1M | Buy |
86,590
+305
| +0.4% | +$129K | 0.07% | 219 |
|
|
2014
Q4 | $35.4M | Buy |
86,285
+5,430
| +7% | +$2.14M | 0.06% | 227 |
|
|
2014
Q3 | $29.1M | Buy |
80,855
+4,865
| +6% | +$1.63M | 0.05% | 257 |
|
|
2014
Q2 | $21.5M | Sell |
75,990
-26,610
| -26% | -$7.89M | 0.04% | 317 |
|
|
2014
Q1 | $30.8M | Sell |
102,600
-16,100
| -14% | -$4.96M | 0.06% | 230 |
|
|
2013
Q4 | $32.7M | Sell |
118,700
-2,300
| -2% | -$662K | 0.06% | 209 |
|
|
2013
Q3 | $37.9M | Sell |
121,000
-4,300
| -3% | -$1.13M | 0.08% | 184 |
|
|
2013
Q2 | $28.2M | Buy |
+125,300
| New | +$29.2M | 0.06% | 210 |
|
Other funds holding REGN
VCM
N
TD Asset Management's REGN Position: Q1 2026 in Review
TD Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2026, selling an estimated $35.7M and leaving 350,923 shares worth $271M. The position accounts for 0.22% of the portfolio, ranked #87.
TD Asset Management first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $369M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- TD Asset Management held 350,923 shares of Regeneron Pharmaceuticals worth $271M as of Q1 2026.
- TD Asset Management sold 46,629 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $35.7M.
- Regeneron Pharmaceuticals made up 0.22% of TD Asset Management's portfolio in Q1 2026, its #87 holding.
- TD Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- TD Asset Management's Regeneron Pharmaceuticals position peaked at $369M in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.